Maa: Etelä-Afrikka
Kieli: englanti
Lähde: South African Health Products Regulatory Authority (SAHPRA)
Adcock
INDICATIONS [/za_1043.html#1] [/za_1043.html#1] [/za_1043.html#1] CONTRA-INDICATIONS [/za_1043.html#1] [/za_1043.html#1] DOSAGE [/za_1043.html#1] [/za_1043.html#1] SIDE-EFFECTS [/za_1043.html#1] [/za_1043.html#1] [/za_1043.html#1] PREGNANCY [/za_1043.html#1] [/za_1043.html#1] OVERDOSE [/za_1043.html#1] IDENTIFICATION [/za_1043.html#1] [/za_1043.html#1] PATIENT INFORMATION FEROFOLIC TABLETS SCHEDULING STATUS Unscheduled PROPRIETARY NAME (and dosage form) FEROFOLIC TABLETS COMPOSITION Controlled-released dose form of iron in a patented vehicle, the GRADUMET Each tablet contains: FERROUS SULPHATE (equivalent to 105 mg elemental iron) 525 mg ASCORBIC ACID ( VITAMIN C ) 500 mg FOLIC ACID 350 micrograms PHARMACOLOGICAL CLASSIFICATION A 8.3 Erythropoietics (haematinics) PHARMACOLOGICAL ACTION Oral iron is absorbed better when administered between meals: however, conventional iron preparations often cause gastric irritation when taken on an empty stomach. Studies with GRADUMET iron have indicated that relatively little of the iron is released in the stomach, the major portion being released in the upper intestinal tract. It is an inert, porous, plastic matrix, in which ferrous sulphate is impregnated. Iron is leached from the GRADUMET as it passes through the gastro-intestinal tract, and the expended matrix is excreted harmlessly in the stool. Thus, the possibility of gastric irritation is minimised when iron is administered in the GRADUMET form in comparison with conventional oral iron preparations. Controlled-release iron, therefore, is beneficial to patients who have a demonstrated intolerance to oral iron preparations. Some investigators have shown that large amounts of ascorbic acid administered orally with ferrous sulphate im Lue koko asiakirja